BLISSGVSNSEBliss GVS Pharma Limited· PharmaceuticalsLowNeutral
Announced Fri, 19 Jun · 19:42 IST

Bliss GVS Pharma informs shareholders about TDS on final dividend

Corporate Actions View source PDF

BLISSGVS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-3.6%1-day move
₹487.00
prior close
₹488.80
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.2-1.7-1.2-1.7-3.6-5.3+0.9+9.0+10.8+7.9+7.0-8.1
Up moveDown movePending
AI summary

Bliss GVS Pharma has notified shareholders about tax deduction at source on its final dividend of Re 1.00 per share (face value Re 1) for FY 2025-26. Record date is July 8, 2026, and AGM is July 15, 2026. TDS will be 10 percent for resident shareholders with valid PAN and 20 percent without PAN or if PAN is not linked with Aadhaar. Non-residents face 20 percent TDS plus surcharge and cess. Shareholders must submit required documents such as Form 121 by July 8, 2026 to claim lower or zero TDS rates.

Likely market impact

Shareholders must submit PAN and TDS exemption documents by July 8, 2026 record date to avoid higher tax deduction on the Rs 1 per share dividend.